Exploring how RB1 deficiency drives metabolic reprogramming in cancer cells and the therapeutic implications of targeting these vulnerabilities.
Explore how computational approaches are revolutionizing cancer drug discovery through in silico screening for leucine aminopeptidase inhibitors with 3,4-dihydroisoquinoline scaffold
Discover how detached cancer cells rewire their metabolism to survive and spread, revealed through advanced 13C Flux Analysis.
Discover how 2-Deoxy-D-glucose (2-DG) tricks cancer cells by disrupting their glycosylation process, offering a promising new approach to cancer treatment.
Discover how computational biology is revolutionizing cancer drug discovery by targeting CDK2 with phytochemicals from plants.
Discover how alcohol and catechol work together with nitrosamines to dramatically increase esophageal cancer risk through groundbreaking animal research.
Exploring how P-glycoprotein expels both chemotherapy drugs and their metabolites, creating formidable cancer resistance
Exploring how the tumor microenvironment controls cancer metabolism and impacts treatment effectiveness